Analyst firms · Ladenburg Thalmann · CMPX
Ladenburg Thalmann CMPX price target and rating history
Compass Therapeutics Inc. (CMPX) · Health Care
Ladenburg Thalmann rates Compass Therapeutics Inc. (CMPX) Buy with a $5 price target, as of its latest action on Jul 1, 2026. It has published 3 rating actions on CMPX since March 2022, including 1 upgrade and 0 downgrades. Across 5 firms with a CMPX price target in the last 12 months, the median target is $10. Ladenburg Thalmann's $5 is 50% below that.
- Current rating
- Buy
- Price target
- $5
- Median target, all firms
- $10
- Actions on CMPX
- 3
Ladenburg Thalmann price target on CMPX
Every Ladenburg Thalmann rating on CMPX
- Jul 1, 2026
- Sep 16, 2024
- Mar 15, 2022
How other firms rate CMPX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wedbush | Neutral | $1 | Sep 23, 2026 |
| Ladenburg Thalmann | Buy | $5 | Jul 1, 2026 |
| Raymond James | Mkt Perform | Apr 28, 2026 | |
| Craig-Hallum | Buy | $15 | Feb 13, 2026 |
| William Blair | Outperform | Jan 5, 2026 | |
| Citizens JMP | Mkt Outperform | $10 | Dec 3, 2025 |
| Canaccord Genuity | Buy | $10 | Dec 3, 2025 |
| Cantor Fitzgerald | Overweight | Dec 3, 2025 |
Questions about Ladenburg Thalmann and CMPX
- What is Ladenburg Thalmann's price target for CMPX?
- Ladenburg Thalmann's latest stated price target for Compass Therapeutics Inc. (CMPX) is $5, from its action on Jul 1, 2026.
- What is Ladenburg Thalmann's rating on CMPX?
- Ladenburg Thalmann rates CMPX Buy, a bullish rating, as of Jul 1, 2026.
- When did Ladenburg Thalmann last change its view on CMPX?
- On Jul 1, 2026, Ladenburg Thalmann resumes coverage at Buy, price target $5.
- How does Ladenburg Thalmann's CMPX target compare with other analysts?
- Across 5 firms with a CMPX price target in the last 12 months, the median target is $10. Ladenburg Thalmann's $5 is 50% below that.
More CMPX rating histories
All Ladenburg Thalmann ratingsCMPX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.